S. Sean Tu
- Cell Biology top 5%
- Molecular Biology top 10%
-
- Biosimilars and Bioanalytical Methods 10
-
- Pharmaceutical Economics and Policy 29
- Health Systems, Economic Evaluations, Quality of Life 13
-
- Intellectual Property and Patents 23
-
- Biomedical Ethics and Regulation 9
-
- Pharmaceutical studies and practices 8
-
- Science, Research, and Medicine 6
-
- Inhalation and Respiratory Drug Delivery 4
- Co-authors
- Richard A. CerioneWen Jin WuDouglas R. GreenHelen M. BeereRyan OyerGary L. JohnsonSpencer B. GibsonSteven M. Anderson
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
S. Sean Tu
51 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 115
- Cell Biology 225
- Molecular Biology 714
- Oncology 188
- Immunology 137
- Immunology and Allergy 36
Countries citing papers authored by S. Sean Tu
This map shows the geographic impact of S. Sean Tu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Sean Tu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Sean Tu more than expected).
Fields of papers citing papers by S. Sean Tu
This network shows the impact of papers produced by S. Sean Tu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Sean Tu. The network helps show where S. Sean Tu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside S. Sean Tu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 5 | |
| 8 | 2024 | 1 | |
| 9 | 2024 | 0 | |
| 10 | 2023 | 7 | |
| 11 | 2023 | 5 | |
| 12 | 2023 | 0 | |
| 13 | 2023 | 7 | |
| 14 | 2023 | 2 | |
| 15 | 2023 | 2 | |
| 16 | Invalidated Patents and Associated Patent Examiners | 2015 | 1 |
| 17 | Understanding the Backlog Problems Associated with Requests for Continued Examination Practice | 2015 | 1 |
| 18 | Patent Examination and Litigation Outcomes | 2014 | 1 |
| 19 | 2010 | 1 | |
| 20 | 1999 | 223 |
About S. Sean Tu
S. Sean Tu is a scholar working on Management of Technology and Innovation, Economics and Econometrics and Reproductive Medicine, having authored 63 papers that have together received 1.1k indexed citations. Recurring topics across this work include Pharmaceutical Economics and Policy (29 papers), Intellectual Property and Patents (23 papers), Health Systems, Economic Evaluations, Quality of Life (13 papers), Biosimilars and Bioanalytical Methods (10 papers), Biomedical Ethics and Regulation (9 papers), Pharmaceutical studies and practices (8 papers), Science, Research, and Medicine (6 papers) and Inhalation and Respiratory Drug Delivery (4 papers). The work is most often cited by research in Cell Biology (225 citations), Molecular Biology (714 citations) and Oncology (188 citations). S. Sean Tu has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Richard A. Cerione, Wen Jin Wu, Douglas R. Green, Helen M. Beere, Ryan Oyer, Gary L. Johnson, Spencer B. Gibson, Steven M. Anderson, Louis-Martin Boucher and Tak W. Mak. Their work appears in journals such as JAMA, Nature Biotechnology, New England Journal of Medicine, Journal of Biological Chemistry and Health Affairs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.